Search

Medical oncologist Chau Dang explains that patients living with metastatic breast cancer have more treatment options than ever before.

… Thursday, October 27, 2016 Summary Metastatic breast cancer is a challenging disease to treat, and for that reason there are many efforts focused on helping patients to live longer and with fewer side effects. Thanks to advances in clinical care, patients with metastatic breast cancer have more treatment

Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics.

… Friday, January 24, 2014 Summary Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics. Simon Powell, Chair of the Department of Radiation Oncology

MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers.

… Thursday, February 25, 2021 MSK today announced it is a founding member of Break Through Cancer , a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers. The foundation is being launched with a $250 million matching gift challenge

A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe.

… Saturday, December 10, 2011 A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe. Improving the effectiveness of such transplants, while at the same time reducing side effects, is an important

Learn how a mentoring program at Memorial Sloan Kettering Cancer Center helped two nurses excel in their roles.

… Monday, August 23, 2021 Some nurses administer lifesaving treatments. Some conduct research. Some educate the next generation of nurses. And that’s just scratching the surface. At their core, nurses want to help others, whether that means patients and families or their own colleagues. Recognizing that

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising early-career investigators.

… Friday, December 1, 2017 Paul Marks prize medal The prize medal features an image of Paul Marks, who led MSK for nearly two decades. MSK President and CEO Craig Thompson MSK President and CEO Craig Thompson presented the honorees with their medals and award checks during a luncheon held before the symposium

For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.

… Tuesday, November 6, 2012 Summary For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world. For the first time, our annual Major Trends in Modern Cancer Research seminar for high school

Learn about former MSK postdoctoral scientist Cornelius Taabazuing, who now leads his own laboratory at University of Pennsylvania.

… Wednesday, September 25, 2024 Cornelius Taabazuing, PhD, cuts right to the chase when asked what advice he would give someone considering whether to join Memorial Sloan Kettering Cancer Center (MSK) as a postdoctoral researcher. “It’s a no-brainer,” he says with a laugh. “You work with brilliant people

Memorial Sloan Kettering Cancer Center (MSK) announced today that Ross Levine, MD, has been named MSK’s new Chief Scientific Officer (CSO). A renowned physician-scientist, Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital (MH) and holds the Edward P. Evans Endowed Chair for Myelodysplastic Syndromes at MSK.

… Thursday, October 16, 2025 Memorial Sloan Kettering Cancer Center (MSK) announced today that Ross Levine, MD , has been named MSK’s new Chief Scientific Officer (CSO). A renowned physician-scientist, Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital

In response to the intense fear that so many people experience around imaging tests, MSK radiology nurses developed new recommendations that are helping patients everywhere.

… Thursday, September 11, 2025 The cancer may be gone, but for many patients the medical tests continue, and so do the fear and worry.  Now, a group of radiology nurses at Memorial Sloan Kettering Cancer Center (MSK) say it’s time to bring awareness — and relief — to the countless patients and their caregivers